S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.05%) $0.926
USD/NOK
(-0.06%) $10.83
USD/GBP
(-0.09%) $0.792
USD/RUB
(-0.09%) $92.49

Realtime updates for Novo Nordisk A/S [NOVO-B.CO]

Exchange: CPH Sector: Healthcare Industry: Biotechnology
Last Updated27 Mar 2024 @ 11:59

-0.79% DKK 881.30

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 11:59):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease...

Stats
Today's Volume 2.45M
Average Volume 2.73M
Market Cap 3 966.08B
EPS DKK0 ( 2024-01-30 )
Next earnings date ( DKK5.38 ) 2024-05-01
Last Dividend DKK0 ( N/A )
Next Dividend DKK0 ( N/A )
P/E 47.33
ATR14 DKK0.656 (0.07%)

Volume Correlation

Long: 0.00 (neutral)
Short: -1.00 (very strong negative)
Signal:(37.538) Neutral

Novo Nordisk A/S Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Novo Nordisk A/S Correlation - Currency/Commodity

The country flag 0.52
( weak )
The country flag -0.13
( neutral )
The country flag 0.12
( neutral )
The country flag 0.36
( neutral )
The country flag -0.13
( neutral )
The country flag -0.14
( neutral )

Novo Nordisk A/S Financials

Annual 2023
Revenue: DKK232.26B
Gross Profit: DKK196.50B (84.60 %)
EPS: DKK18.67
Q4 2023
Revenue: DKK65.86B
Gross Profit: DKK55.85B (84.80 %)
EPS: DKK4.92
Q3 2023
Revenue: DKK58.73B
Gross Profit: DKK49.02B (83.46 %)
EPS: DKK5.02
Q2 2023
Revenue: DKK54.30B
Gross Profit: DKK46.44B (85.53 %)
EPS: DKK8.65

Financial Reports:

No articles found.

Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators